Interleukin-12 in early or advanced cancer patients

European Journal of Cancer

Volumn 33, Issue 10, 1997, Pages 1703-1705

  Lissoni, P ^a   Rovelli, F ^a   Pittalis, S ^a   Casati, M ^a   Perego, M S ^a   Grassi, M G ^a   Brivio, F ^a   Fumagalli, L ^b  

^a SAN GERARDO HOSPITAL   (Italy)

^b Chiron Italia   (Italy)

Author keywords

Cancer immunotherapy; Interleukin 10; Interleukin 12; Interleukin 2; Interleukin 6

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY CANCER; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PRIORITY JOURNAL; SOLID TUMOR;

ADULT; AGED; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-6; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS;

EID: 0031427406     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00180-9     Document Type: Article

References (10)

1. Matsuda T, Hirano T. Interleukin-6 (IL-6). Biotherapy 1990, 2, 363-373.
2. Tartour E, Dorval T, Mosseri V, et al. Serum, interleukin-6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients. Br J Cancer 1994, 69, 911-913.
3. Moore KW, O'Garra A, De Waal-Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Ann Rev Immunol 1993, 11, 165-199.
4. Rosenberg SA. The immunotherapy and gene therapy of cancer. J Clin Oncol 1992, 10, 180-199.
5. Brunda MJ, Luistro L, Warrier RR, et al. Antitumor and anti-metastatic activity of interleukin 12 against murine tumors. J Exp Med 1993, 178, 1223-1230.
6. Lissoni P, Barni S, Rovelli F, Tancini G. Lower survival in metastatic cancer patients with reduced interleukin-2 blood concentrations: preliminary report. Oncology 1991, 48, 125-127.
7. Banks RE, Patel PM, Selby PJ. Interleukin 12: a new clinical player in cytokine therapy. Br J Cancer 1995, 71, 655-659.
8. Lissoni P, Rovelli F, Tisi E, et al. Relation between macrophage and T helper-2 lymphocyte functions in human neo-plasms: neopterin, interleukin-10 and interleukin-6 blood levels in early or advanced solid tumors. J Biol Regul Homeost Agents 1995, 9, 146-149.
9. Lissoni P, Barni S, Fumagalli L, et al. A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha, and soluble interleukin-2 receptors. J Biol Regul Homeost Agents 1994, 8, 32-35.
10. Foon KA. Biological response modifiers: the new immunotherapy. Cancer Res 1989, 49, 1621-1639.